ZYRUBIA Trademark

Trademark Overview

On Monday, September 24, 2012, a trademark application was filed for ZYRUBIA with the United States Patent and Trademark Office. The USPTO has given the ZYRUBIA trademark a serial number of 85736701. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, January 18, 2017. This trademark is owned by Glaxo Group Limited. The ZYRUBIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain associated with rheumatoid arthritis, inflammation, rheumatoid arthritis, sepsis, alopecia, obesity; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines; all of the foregoing specifically excluding pharmaceutical preparations and substances acting on the central nervous system, pharmaceutical preparations and substances for the treatment and/or management of, sleep disorders, cognitive disorders, narcolepsy, and neurological or psychiatric diseases or disorders
zyrubia

General Information

Serial Number85736701
Word MarkZYRUBIA
Filing DateMonday, September 24, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, January 18, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain associated with rheumatoid arthritis, inflammation, rheumatoid arthritis, sepsis, alopecia, obesity; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines; all of the foregoing specifically excluding pharmaceutical preparations and substances acting on the central nervous system, pharmaceutical preparations and substances for the treatment and/or management of, sleep disorders, cognitive disorders, narcolepsy, and neurological or psychiatric diseases or disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 27, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, January 30, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 30, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 19, 2016EXTENSION 5 GRANTED
Monday, July 11, 2016EXTENSION 5 FILED
Monday, July 11, 2016TEAS EXTENSION RECEIVED
Friday, December 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 10, 2015EXTENSION 4 GRANTED
Tuesday, December 1, 2015EXTENSION 4 FILED
Tuesday, December 1, 2015TEAS EXTENSION RECEIVED
Saturday, July 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 10, 2015EXTENSION 3 GRANTED
Tuesday, July 7, 2015EXTENSION 3 FILED
Tuesday, July 7, 2015TEAS EXTENSION RECEIVED
Tuesday, June 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 22, 2014EXTENSION 2 GRANTED
Thursday, December 18, 2014EXTENSION 2 FILED
Thursday, December 18, 2014TEAS EXTENSION RECEIVED
Friday, August 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 7, 2014EXTENSION 1 GRANTED
Thursday, July 10, 2014EXTENSION 1 FILED
Tuesday, August 5, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 10, 2014TEAS EXTENSION RECEIVED
Tuesday, January 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 4, 2013TTAB RELEASE CASE TO TRADEMARKS
Wednesday, December 4, 2013OPPOSITION TERMINATED NO. 999999
Wednesday, December 4, 2013OPPOSITION DISMISSED NO. 999999
Friday, November 22, 2013PAPER RECEIVED
Monday, August 26, 2013OPPOSITION INSTITUTED NO. 999999
Thursday, June 6, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 6, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 20, 2013EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 23, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 15, 2013ASSIGNED TO EXAMINER
Thursday, September 27, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 27, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

zyrubia pharmaceutical substances preparations disorders treatment diseases arthritis rheumatoid system tissue